Filing Details
- Accession Number:
- 0000899243-20-013561
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 16:05:33
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-05-19 16:05:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1447362 | Castle Biosciences Inc | CSTL | Services-Medical Laboratories (8071) | 770701744 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1572764 | Mgc Venture Partners 2013, L.p. | C/O Mountain Group Capital, Llc 3835 Cleghorn Ave., Suite 300 Nashville TN 37215 | No | No | Yes | No | |
1745133 | Mgc Venture Partners 2018, L.p. | C/O Mountain Group Capital, Llc 3835 Cleghorn Ave., Suite 300 Nashville TN 37215 | No | No | Yes | No | |
1749814 | Mgc Venture Partners Qp 2018, L.p. | C/O Mountain Group Capital, Llc 3835 Cleghorn Ave., Ste. 300 Nashville TN 37215 | No | No | Yes | No | |
1783291 | Mgc Venture Partners 2018 Gp, Llc | C/O Mountain Group Capital, Llc 3835 Cleghorn Ave., Suite 300 Nashville TN 37215 | No | No | Yes | No | |
1783292 | Mgc Venture Partners 2013 Gp, Llc | C/O Mountain Group Capital, Llc 3835 Cleghorn Ave., Suite 300 Nashville TN 37215 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-15 | 13,799 | $36.39 | 1,472,137 | No | 4 | S | Indirect | See footnotes |
Common Stock | Disposition | 2020-05-15 | 8,117 | $37.28 | 1,464,020 | No | 4 | S | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 115,300 | Indirect | See footnotes |
Common Stock | 134,700 | Indirect | See footnotes |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020.
- This transaction was executed in multiple trades at prices ranging from $36.00 to $36.98, inclusive. The price reported above reflects the weighted-average sale price. MGC 2013 LP hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held directly by MGC 2013 LP.
- MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP") is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC Venture Partners 2018, L.P. ("MGC 2018 LP") and MGC Venture Partners QP 2018, L.P. ("MGC QP 2018 LP"). Each of MGC 2013 LP, MGC 2013 GP, MGC 2018 LP, MGC QP 2018 LP and MGC 2018 GP directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of some or all of the shares owned by MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP and, therefore, a "ten percent holder" hereunder.
- Each of Joseph C. Cook, Jr., Joseph C. Cook III, Steven D. Singleton and Byron W. Smith are managing directors of MGC 2013 GP and share voting and investment power over the shares held by MGC 2013 LP. Each of Joseph C. Cook, Jr., Joseph C. Cook III, Steven D. Singleton, Byron W. Smith, Jay Ferguson and Rob Readnour are managing partners of MGC 2018 GP and share voting and investment power over the shares held by MGC 2018 LP and MGC QP 2018 LP. Each of the reporting persons disclaims beneficial ownership of the shares held by any other reporting persons reported herein, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the reporting persons are the beneficial owners of such securities for purposes of Section 16 or for any other purposes.
- This transaction was executed in multiple trades at prices ranging from $37.00 to $37.50, inclusive. The price reported above reflects the weighted-average sale price. MGC 2013 LP hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Reflects number of shares owned as of May 15, 2020.
- Held directly by MGC 2018 LP.
- Held directly by MGC QP 2018 LP.